Vext Science (VEXT.CN) Stock Price

Vext Science Price

CSE·CLOSED
0.21USD+0.00 (+0.00 %)
Market closed

Revenue has compounded at 14.3% per year over the past 8 years to 36.00 M USD. Earnings per share have declined at 27.6% per year over the last 7 years. Vext Science's net margin stands at -62.3%, down from 8.4% several years earlier. Analysts set a median price target of 0.30 USD, implying 41.2% above the current price. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus. Over the past year Vext Science shares have gained 7.4%. The stock trades about 53% above its 52-week low.

Vext Science stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Vext Science over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Vext Science stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Vext Science's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Vext Science Stock Price History
DateVext Science Price
8/25/20260.21 USD
8/24/20260.21 USD
8/21/20260.21 USD
8/20/20260.21 USD
8/19/20260.20 USD
8/18/20260.20 USD
8/17/20260.20 USD
8/14/20260.20 USD
8/13/20260.20 USD
8/12/20260.20 USD
8/11/20260.20 USD
8/10/20260.18 USD
8/7/20260.18 USD
8/6/20260.18 USD
8/5/20260.18 USD
8/4/20260.18 USD
7/31/20260.18 USD
7/30/20260.18 USD
7/29/20260.18 USD
7/28/20260.17 USD
7/27/20260.18 USD
7/24/20260.18 USD
7/23/20260.18 USD
7/22/20260.17 USD
7/21/20260.18 USD
7/20/20260.18 USD
7/17/20260.18 USD
7/16/20260.18 USD
7/15/20260.18 USD
7/14/20260.18 USD
7/13/20260.18 USD
7/10/20260.17 USD
7/9/20260.16 USD
7/8/20260.16 USD
7/7/20260.17 USD
7/6/20260.17 USD
7/3/20260.16 USD
7/2/20260.17 USD
6/30/20260.16 USD
6/29/20260.17 USD
6/26/20260.17 USD
6/25/20260.19 USD
6/24/20260.18 USD
6/23/20260.18 USD
6/22/20260.18 USD
6/19/20260.18 USD
6/18/20260.18 USD
6/17/20260.19 USD
6/16/20260.18 USD
6/15/20260.19 USD
6/12/20260.20 USD
6/11/20260.19 USD
6/10/20260.19 USD
6/9/20260.19 USD
6/8/20260.19 USD
6/5/20260.19 USD
6/4/20260.19 USD
6/3/20260.18 USD
6/2/20260.17 USD
6/1/20260.18 USD
5/29/20260.19 USD
5/28/20260.20 USD
5/27/20260.20 USD
5/26/20260.20 USD
5/25/20260.20 USD
5/22/20260.19 USD
5/21/20260.20 USD
5/20/20260.20 USD
5/19/20260.20 USD
5/15/20260.21 USD
5/14/20260.21 USD
5/13/20260.21 USD
5/12/20260.21 USD
5/11/20260.23 USD
5/8/20260.23 USD
5/7/20260.25 USD
5/6/20260.24 USD
5/5/20260.25 USD
5/4/20260.23 USD
5/1/20260.25 USD
4/30/20260.25 USD
4/29/20260.23 USD
4/28/20260.20 USD
4/27/20260.20 USD
4/24/20260.20 USD
4/23/20260.20 USD
4/22/20260.21 USD
4/21/20260.20 USD
4/20/20260.20 USD
4/17/20260.20 USD
4/16/20260.19 USD
4/15/20260.19 USD
4/14/20260.20 USD
4/13/20260.21 USD
4/10/20260.20 USD
4/9/20260.20 USD
4/8/20260.19 USD
4/7/20260.19 USD
4/6/20260.20 USD
4/2/20260.19 USD
4/1/20260.19 USD
3/31/20260.18 USD
3/30/20260.17 USD
3/27/20260.16 USD
3/26/20260.16 USD
3/25/20260.16 USD
3/24/20260.17 USD
3/23/20260.16 USD
3/20/20260.16 USD
3/19/20260.19 USD
3/18/20260.19 USD
3/17/20260.18 USD
3/16/20260.18 USD
3/13/20260.19 USD
3/12/20260.18 USD
3/11/20260.18 USD
3/10/20260.18 USD
3/9/20260.18 USD
3/6/20260.18 USD
3/5/20260.18 USD
3/4/20260.18 USD
3/3/20260.18 USD
3/2/20260.17 USD
2/27/20260.17 USD
2/26/20260.18 USD
2/25/20260.18 USD
2/24/20260.18 USD
2/23/20260.18 USD
2/20/20260.20 USD
2/19/20260.20 USD
2/18/20260.20 USD
2/17/20260.21 USD
2/13/20260.20 USD
2/12/20260.20 USD
2/11/20260.20 USD
2/10/20260.20 USD
2/9/20260.20 USD
2/6/20260.20 USD
2/5/20260.20 USD
2/4/20260.20 USD
2/3/20260.21 USD
2/2/20260.21 USD
1/30/20260.21 USD
1/29/20260.21 USD
1/28/20260.21 USD
1/27/20260.20 USD
1/26/20260.20 USD
1/23/20260.21 USD
1/22/20260.21 USD
1/21/20260.20 USD
1/20/20260.20 USD
1/19/20260.20 USD
1/16/20260.20 USD
1/15/20260.20 USD
1/14/20260.20 USD
1/13/20260.20 USD
1/12/20260.20 USD
1/9/20260.18 USD
1/8/20260.20 USD
1/7/20260.17 USD
1/6/20260.17 USD
1/5/20260.17 USD
1/2/20260.18 USD
12/31/20250.18 USD
12/30/20250.18 USD
12/29/20250.19 USD
12/24/20250.20 USD
12/23/20250.21 USD
12/22/20250.22 USD
12/19/20250.23 USD
12/18/20250.20 USD
12/17/20250.21 USD
12/16/20250.22 USD
12/15/20250.20 USD
12/12/20250.18 USD
12/11/20250.14 USD
12/10/20250.14 USD
12/9/20250.14 USD
12/8/20250.16 USD
12/5/20250.16 USD
12/4/20250.17 USD
12/3/20250.16 USD
12/2/20250.16 USD
12/1/20250.19 USD
11/28/20250.18 USD
11/27/20250.17 USD
11/26/20250.18 USD
11/25/20250.17 USD
11/24/20250.18 USD
11/21/20250.18 USD
11/20/20250.18 USD
11/19/20250.18 USD
11/18/20250.17 USD
11/17/20250.18 USD
11/14/20250.18 USD
11/13/20250.17 USD
11/12/20250.20 USD
11/11/20250.20 USD
11/10/20250.20 USD
11/7/20250.18 USD
11/6/20250.18 USD
11/5/20250.19 USD
11/4/20250.20 USD
11/3/20250.20 USD
10/31/20250.20 USD
10/30/20250.20 USD
10/29/20250.20 USD
10/28/20250.20 USD
10/27/20250.20 USD
10/24/20250.19 USD
10/23/20250.19 USD
10/22/20250.20 USD
10/21/20250.20 USD
10/20/20250.20 USD
10/17/20250.22 USD
10/16/20250.23 USD
10/15/20250.25 USD
10/14/20250.25 USD
10/10/20250.26 USD
10/9/20250.26 USD
10/8/20250.26 USD
10/7/20250.25 USD
10/6/20250.27 USD
10/3/20250.27 USD
10/2/20250.27 USD
10/1/20250.26 USD
9/30/20250.26 USD
9/29/20250.26 USD
9/26/20250.25 USD
9/25/20250.25 USD
9/24/20250.25 USD
9/23/20250.25 USD
9/22/20250.23 USD
9/19/20250.21 USD
9/18/20250.21 USD
9/17/20250.21 USD
9/16/20250.21 USD
9/15/20250.20 USD
9/12/20250.22 USD
9/11/20250.23 USD
9/10/20250.23 USD
9/9/20250.22 USD
9/8/20250.23 USD
9/5/20250.22 USD
9/4/20250.20 USD
9/3/20250.20 USD
9/2/20250.21 USD
8/29/20250.20 USD
8/28/20250.21 USD
8/27/20250.19 USD
8/26/20250.20 USD
Access this data via the Eulerpool API

Vext Science Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
25.19 M USD
3.45 M USD
2.13 M USD
Jan 1, 2021
37.24 M USD
9.24 M USD
4.99 M USD
Jan 1, 2022
35.41 M USD
7.15 M USD
10.92 M USD
Jan 1, 2023
34.81 M USD
-5.98 M USD
4.40 M USD
Jan 1, 2024
36.00 M USD
-8.22 M USD
-22.44 M USD
Jan 1, 2025 (e)
52.33 M USD
1.12 M USD
-8.86 M USD
Jan 1, 2026 (e)
54.77 M USD
13.26 M USD
-7.09 M USD
Jan 1, 2027 (e)
109.34 M USD
21.83 M USD
14.74 M USD

Vext Science Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 26, 2026, 3:11 PM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
2016201720182019202020212022202320242025e2026e2027e
12.0014.0018.0022.0025.0037.0035.0034.0035.0052.0054.00109.00
16.6728.5722.2213.6448.00-5.41-2.862.9448.573.85101.85
66.6757.1450.0040.9136.0043.2457.1438.2431.4331.4331.4331.43
8.008.009.009.009.0016.0020.0013.0011.0016.3416.9734.26
6.005.005.003.003.009.007.00-5.00-8.001.0013.0021.00
50.0035.7127.7813.6412.0024.3220.00-14.71-22.861.9224.0719.27
4.004.003.002.002.004.0010.004.00-22.00-8.00-7.0014.00
-25.00-33.33100.00150.00-60.00-650.00-63.64-12.50-300.00
18.6718.6718.6721.8347.39146.41139.53164.74240.91240.91240.91240.91
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Vext Science generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Vext Science retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Vext Science's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Vext Science has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Vext Science's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Vext Science stock margins

The Vext Science margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Vext Science. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Vext Science.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
39.68 %
13.70 %
8.43 %
Jan 1, 2021
44.19 %
24.81 %
13.39 %
Jan 1, 2022
59.10 %
20.18 %
30.84 %
Jan 1, 2023
39.78 %
-17.19 %
12.63 %
Jan 1, 2024
33.06 %
-22.84 %
-62.32 %
Jan 1, 2025 (e)
33.06 %
2.14 %
-16.94 %
Jan 1, 2026 (e)
33.06 %
24.21 %
-12.94 %
Jan 1, 2027 (e)
33.06 %
19.96 %
13.48 %

Vext Science Stock Revenue, EBIT, Earnings per Share

The Vext Science earnings per share therefore indicates how much revenue Vext Science has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
0.53 USD
0.07 USD
0.04 USD
Jan 1, 2021
0.25 USD
0.06 USD
0.03 USD
Jan 1, 2022
0.25 USD
0.05 USD
0.08 USD
Jan 1, 2023
0.21 USD
-0.04 USD
0.03 USD
Jan 1, 2024
0.15 USD
-0.03 USD
-0.09 USD
Jan 1, 2025 (e)
0.22 USD
0.00 USD
-0.04 USD
Jan 1, 2026 (e)
0.23 USD
0.06 USD
-0.03 USD
Jan 1, 2027 (e)
0.45 USD
0.09 USD
0.06 USD

Vext Science business model & stock analysis

Vext Science Inc. is a Canadian company specializing in the production and sale of cannabis products. The company was established in 2015 and has gained a high reputation due to its innovative business models and quality, effective products. Vext Science Inc. aims to make cannabis products accessible for various applications while meeting the highest standards. The company works closely with cannabis breeders to obtain the best quality cannabis products, with a focus on organic and natural cultivation. Vext Science Inc. operates in three divisions: Vapen, Vapen CBD, and Pure Touch Botanicals. The Vapen division produces and distributes traditional cannabis products such as flowers, capsules, and oils. Vapen CBD offers a wide range of CBD products, including oils, creams, lotions, and capsules. The emphasis in this division is on utilizing the benefits of cannabinoids for pain relief and stress management. Pure Touch Botanicals offers a wide range of natural herbal products for wellness enhancement, including tea, herbal capsules, and supplements. Vext Science Inc.'s business model is based on creating partnerships with other companies and individuals. The company collaborates with immigrants and community members to create jobs and stimulate local economic growth. Vext Science Inc. focuses on an efficient value chain to provide customer-oriented service. Vext Science Inc.'s products are popular among consumers and valued for their quality and natural ingredients. The company places great importance on research and development to ensure its products meet the highest quality standards. The future of Vext Science Inc. looks promising as the company plans further expansion in the coming years. The company aims to bring its products to the global market and expand its product range with specialized supplements. Vext Science Inc. aims to continue offering innovative and high-quality products to promote the well-being and health of its customers. In summary, Vext Science Inc. is a leading company in the cannabis industry specializing in the production and sale of high-quality, natural products. The company prides itself on maintaining an ethical, transparent, and stable business practice built on partnerships. Although Vext Science Inc. is still relatively young, the company demonstrates a clear vision and ambitious plan, indicating a promising future.

Vext Science SWOT Analysis

Strengths

Vext Science Inc has several strengths that contribute to its success in the market. These include: - Strong portfolio of high-quality products that cater to various consumer needs. - Established brand reputation built on trust, reliability, and consistent product quality. - Robust research and development capabilities, enabling continuous innovation and product improvement. - Well-established distribution channels and strategic partnerships that provide a wide market reach. - Experienced and knowledgeable management team with a deep understanding of the industry. - Strong financial position and sustainable revenue growth.

Weaknesses

Although Vext Science Inc has achieved significant success, it also faces certain weaknesses that need to be addressed: - Dependency on a limited number of key suppliers, exposing the company to supply chain risks. - Reliance on a specific geographic market, making it vulnerable to regional economic changes or regulations. - Limited brand awareness in certain markets, requiring increased marketing and promotional efforts. - Lack of diversification in product offerings, potentially limiting market opportunities. - Higher production costs compared to some competitors, impacting profit margins.

Opportunities

Vext Science Inc can capitalize on various opportunities to further enhance its market position: - Growing consumer demand for cannabis-based products and increasing legalization worldwide. - Expansion into new markets and geographic regions to tap into unexplored customer segments. - Development of innovative products that cater to emerging trends and customer preferences. - Strategic partnerships with complementary businesses to introduce new distribution channels. - Leveraging technology advancements for product development, manufacturing efficiency, and market targeting.

Threats

Vext Science Inc must be wary of potential threats that could hinder its growth and profitability: - Intense competition from both established players and new entrants in the cannabis industry. - Evolving regulatory landscape and potential changes in government policies impacting the market. - Potential negative perception or stigma associated with cannabis products in certain markets. - Fluctuating commodity prices and supply chain disruptions affecting production costs and availability. - Economic downturns or recessions that may impact consumer spending on non-essential items.

Vext Science Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Vext Science historical P/E ratio, EBIT multiple, and P/S ratio

Vext Science annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Vext Science shares outstanding

The number of shares of Vext Science was 240.91 M in 2025. This indicates how many shares Vext Science is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
47.39 M Stocks
Jan 1, 2021
146.41 M Stocks
Jan 1, 2022
139.53 M Stocks
Jan 1, 2023
164.74 M Stocks
Jan 1, 2024
240.91 M Stocks
Jan 1, 2025 (e)
240.91 M Stocks
Jan 1, 2026 (e)
240.91 M Stocks
Jan 1, 2027 (e)
240.91 M Stocks

Current Vext Science forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
87.50 % (7)
Hold
12.50 % (1)
Sell
0.00 % (0)
12M Price Target
0.00
Last Price
0.00
Currency
USD
12M Return Potential
0 %
LTM Return
0 %

Vext Science Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
3/20/2024-0.01USD-10.66 MUSD-2023 Q4
4/17/20230.01USD-9.51 MUSD-2022 Q4
11/16/2022-USD-8.91 MUSD-2022 Q3
8/24/2022-USD-10.86 MUSD-2022 Q2
5/30/2022-USD-10.20 MUSD-2022 Q1
4/20/20220.01USD-9.15 MUSD-2021 Q4
11/18/20210.01USD-9.77 MUSD-2021 Q3
8/24/20210.01USD-9.93 MUSD-2021 Q2

Vext Science shareholder structure

% Name
31.54286%
LLF Financial SA
LLF Financial SA
0.91854%
Offenberger (Eric Jay)
Offenberger (Eric Jay)
0.90232%
Opzoomer (Mark William)
Opzoomer (Mark William)
0.67109%
Phanos (Spiro Alexander)
Phanos (Spiro Alexander)
0.59162%
Nguyen (Jason T)
Nguyen (Jason T)
0.49037%
Johns (David)
Johns (David)

Frequently asked questions about Vext Science

The business model of Vext Science Inc revolves around the cultivation, manufacture, and distribution of high-quality cannabis products. As a leading cannabis operator, Vext Science Inc focuses on producing premium cannabis flower, extracts, edibles, and topicals for both medical and recreational use. With a vertically integrated approach, the company manages the entire production process from cultivation to retail, ensuring the highest standards of product quality and consistency. By leveraging its expertise in the cannabis industry, Vext Science Inc aims to establish a strong presence in key markets, deliver exceptional products, and drive sustainable growth.

Vext Science Inc is primarily active in the cannabis industry.

The main competitors of Vext Science Inc in the market include other companies operating in the cannabis industry such as Canopy Growth Corporation, Aurora Cannabis Inc, and Cronos Group Inc. These companies are all actively engaged in the cultivation, production, and distribution of cannabis-related products and services. However, it's important to note that the competitive landscape in the cannabis industry is dynamic, with new entrants continuously emerging. Vext Science Inc faces competition from both well-established players and smaller companies striving to gain market share in this rapidly growing industry.

Vext Science Inc is a renowned cannabis company with a rich history and background. Established in 2015, Vext Science specializes in the cultivation, production, and distribution of premium cannabis products. Based in Vancouver, Canada, the company operates multiple cultivation facilities across Arizona, USA. With a focus on delivering high-quality cannabis and related products, Vext Science has positioned itself as a leading player in the industry. The company's commitment to innovation, sustainability, and customer satisfaction has contributed to its significant growth and success. Vext Science Inc continues to expand its operations and partnerships, ensuring its prominent presence in the cannabis market.

Vext Science Inc has achieved several significant milestones in its journey. The company has successfully expanded its operations, establishing a strong presence in the cannabis industry. Vext Science Inc has also made strategic acquisitions, broadening its product portfolio and market reach. Additionally, the company has demonstrated consistent revenue growth and profitability, reflecting its successful business model. Vext Science Inc has also prioritized corporate social responsibility, fostering positive relationships within the communities it operates in. These milestones exemplify Vext Science Inc's commitment to success, innovation, and delivering value to its shareholders and stakeholders.

Vext Science Inc is primarily present in the United States and Canada.

Vext Science Inc represents a commitment to excellence, innovation, and shareholder value. With a strong corporate philosophy focused on sustainable growth and ethical business practices, Vext Science Inc aims to lead the industry by providing high-quality cannabis products and services. The company prioritizes customer satisfaction, transparency, and community engagement. Vext Science Inc believes in fostering partnerships and collaborations to ensure long-term success and industry leadership. Through its dedication to quality and continuous improvement, Vext Science Inc is positioned to deliver value to its stakeholders and contribute to the overall growth of the cannabis sector.

8 analysts currently rate the Vext Science stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Vext Science to generate revenue of 54.77 M USD and earnings per share of -0.03 USD.

Converted at the current exchange rate, the Vext Science share trades at 0.18 EUR (0.21 USD).

The Vext Science share (VEXT.CN) is listed on 5 stock exchanges, including: Frankfurt (VV5.F), München (VV5.MU).

Vext Science Inc. is a leading manufacturer and marketer of cannabis plants and consumer goods in North America. The company operates in multiple business areas and offers a variety of products based on different customer needs and preferences. With its wide range of products, forward-looking business models, and innovative approaches, Vext Science Inc. has established itself as one of the key players in the industry. The company operates unique production facilities specifically designed for the cultivation of high-quality cannabis plants. These facilities are constructed to provide optimal conditions for cannabis plant growth, including climate control, lighting, and humidity. Furthermore, the company's extensive experience and expertise in the cannabis industry allow for high-volume and quality scaling. An important division of Vext Science Inc. is the marketing of its own consumer goods. This includes both medical and non-medical products such as CBD oil and capsules, extracts, and edibles, sold under the brand "Vapen". These products are available online and in retail stores. The "Vapen" brand is known for its high quality standards and unique product design, and has already gained significant recognition in the industry. Another crucial division of Vext Science Inc. is the processing and sale of raw materials and materials for use in the cannabis industry. This includes hash, terpenes, and isolated cannabinoids. By distributing these raw materials and materials, the company enables businesses in the cannabis industry to optimize their own productions and simplify the manufacturing of their own consumer goods. Another important aspect of the business model is collaboration with other companies and the expansion of partnerships. Vext Science Inc. works with companies throughout the cannabis industry to enhance its products and services, promote the exchange of expertise, and develop new business models and opportunities. In summary, the business model of Vext Science Inc. focuses on the close integration of cannabis plant cultivation, processing, and marketing. The company emphasizes production optimization and portfolio expansion, while expanding its presence in the industry through partnerships and collaborations. With its wide range of products and services, as well as industry expertise, Vext Science Inc. has established itself as a key player that will continue to play an important role in the cannabis industry in the future.

The expected revenue of Vext Science is 54.77 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Vext Science is -7.09 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Vext Science is currently -7.12. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Vext Science stock.

The price-to-sales ratio (P/S) of Vext Science is currently 0.92. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Vext Science stock.

The Eulerpool Quality Score for Vext Science is 1/10.

The ISIN of Vext Science is CA9255401064. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Vext Science is A2PVB0. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Vext Science is VEXT.CN. The ticker symbol is used to trade Vext Science shares on the stock exchange.

Vext Science paid dividends every year for the past 0 years.

Vext Science is assigned to the 'Health' sector.

The dividends of Vext Science are distributed in USD.

All fundamentals and in-depth analysis of Vext Science

Our stock analysis for Vext Science stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vext Science. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.